UK: Clarivate shares jump higher on announcement of plans to sell Life Sciences &...
UK-headquartered, US-listed Clarivate’s stock price rose by almost 40% on the release of the firm’s decision to sell its Life Sciences & Healthcare business...
France: Ramsay decides on Ramsay Santé shareholding
Ramsay Health Care, , with advisers Goldman Sachs, has completed a strategic review of Ramsay’s share ownership in Ramsay Santé.
It proposes to distribute...
UK: Spire Healthcare confirms discussions on a potential sale with Bridgepoint and Triton
Spire Healthcare, a UK provider of private healthcare, running 38 private hospitals and over 50 clinics, consulting rooms and medical centres, has confirmed it...
Belgium: Aedifica obtains approval for combination with Cofinimmo
The college of the Belgian Competition Authority (BCA) has approved the combination of Aedifica and Cofinimmo to form a leading healthcare REIT in Europe.
The...
Switzerland: Alcon concludes CHF602m share buy-back programme
SIX-listed Alcon, a Switzerland-based global eye care company, has completed a CHF602m (US$750m) share repurchase programme.
In aggregate, 9,301,877 registered shares were acquired on the...
Malaysia: Sunway Healthcare preparing IPO in Malaysia to fund expansion plans
Press reports point to Sunway Healthcare Group (SHG) about to gauge investor interest for its proposed IPO in Malaysia. The IPO could raise around...
US: STAAR to terminate merger agreement with Alcon
Nasdaq-listed STAAR Surgical, a designer, developer and manufacturer of implantable lenses for the eye, has announced that based on preliminary estimates by STAAR’s proxy...
Hong Kong: Insilico Medicine raises US$292m from Hong Kong IPO
Insilico Medicine, a clinical-stage drug discovery and development company, listed on the Hong Kong Stock Exchange at the end of December, becoming the first...
Iceland: Alvotech places US$108m convertible bonds to support development
Nasdaq-listed Alvotech, an Iceland-headquartered global biotech company specialising in biosimilars, has placed US$108m 6.875% senior unsecured convertible bonds due 2030. The initial conversion price...
US: Broadwood recommends investors vote against Alcon’s proposed takeover of STAAR
Broadwood Partners, which owns 30.2% of STAAR’s shares, is recommending shareholders vote against a proposed takeover by Six-listed Alcon for a total equity value of approximately...
Advertisement
